# Trade Mark Journal No.2025/025 20 June 2025

## UK00004213861 4 June 2025 (5)

EXKALBRI

International priority date claimed: 24 January 2025 (European Union Intellectual Property Office (EUIPO)) (019135271)

Class 5
  Pharmaceutical preparations and substances for the treatment of cardiovascular, metabolic, and renal diseases and disorders.

AstraZeneca AB

Representative: Dennemeyer & Company Limited